Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

Boehringer Ingelheim and Click Therapeutics are restructuring their marketing deal for the software-based schizophrenia treatment CT-155, as the German pharma also opens its coffers. Under what the ...

Click Therapeutics is cutting staff just days after announcing a new funding round and taking over commercial work for its experimental digital therapeutic, CT-155. The cuts were confirmed to Fierce ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine. The ...

The Langdon Canadian Smaller Companies Portfolio declined 1.5% in Q1 2026, lagging its benchmark. Read the full analysis for ...

This issue differs from the one where the context menu freezes or opens slowly. Here, users can select an option in the context menu, but the right-click menu gets stuck on the screen after selecting ...

Click Holdings Limited provides human resources solutions in Hong Kong. It operates through three segments: Professional Solution Services, Nursing Solution Services, and Logistics and Other Solution ...

From AI-powered literature reviews to precision search techniques and seamless citation management, today’s research tools can save you hours and boost accuracy. Whether you’re a student or a seasoned ...

CLIK is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of CLIK shares has increased $0.01 since the market last closed. This is a 0.36 ...

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We ...